Experimental rodent models of cardiorenal syndrome types 3 and 4: Insights and clinical relevance (Review)
Open Access
- 4 June 2026
- journal article
- review article
- Published by Spandidos Publications in International Journal of Molecular Medicine
- Vol. 58 (2) , 1-21
Abstract
Cardiorenal syndrome (CRS) encompasses the bidirectional and complex interaction between cardiac and renal dysfunction. The present review focuses on CRS types 3 and 4, highlighting the negative effects of acute kidney injury and chronic kidney disease, respectively, on cardiac function. The present review focuses on pathophysiological mechanisms, associating renal impairment with cardiovascular events, paying particular attention to systemic inflammation, oxidative stress, endothelial damage and neurohormonal activation. From fundamental science to clinical applications, the investigation of CRS remains a challenge. In this context, some experimental models mimicking CRS types 3 and 4 have been used, including 5/6 nephrectomy, unilateral ureteral obstruction, renal ischemia‑reperfusion and adenine‑ or cisplatin‑induced kidney injury. While these models are valuable for studying such disease mechanisms, their limitations in mimicking human pathophysiology are discussed, and their strengths and weaknesses are critically addressed. Advancing and refining preclinical models should be prioritized in future research to enhance clinical relevance and accelerate the development of targeted therapies for CRS.Keywords
This publication has 253 references indexed in Scilit:
- Investigating the cause of cardiovascular dysfunction in chronic kidney disease: capillary rarefaction and inflammation may contribute to detrimental cardiovascular outcomesBasic Research in Cardiology, 2024
- Cardiorenal syndrome: Pathophysiology as a key to the therapeutic approach in an under‐diagnosed diseaseJournal of Clinical Ultrasound, 2022
- Maltol mitigates cisplatin‐evoked cardiotoxicity via inhibiting the PI3K/Akt signaling pathway in rodents in vivo and in vitroPhytotherapy Research, 2022
- Comparative cardioprotective effects of carvedilol versus atenolol in a rat model of cardiorenal syndrome type 4Naunyn-Schmiedeberg's Archives of Pharmacology, 2021
- Lactobacillus supplementation prevents cisplatin-induced cardiotoxicity possibly by inflammation inhibitionCancer Chemotherapy and Pharmacology, 2018
- Assessment of Glomerular Filtration Rate in Health and Disease: A State of the Art ReviewClinical Pharmacology & Therapeutics, 2017
- Taurine protects cisplatin induced cardiotoxicity by modulating inflammatory and endoplasmic reticulum stress responsesBioFactors, 2016
- Investigating mechanisms of chronic kidney disease in mouse modelsPediatric Nephrology, 2011
- Cardiovascular and Noncardiovascular Mortality Among Patients Starting DialysisJAMA, 2009
- Ureteral obstruction in the neonatal rat: Renal nerves modulate hemodynamic effectsPediatric Nephrology, 1995